Table 2.
Results for screening imaging models.
Study, Country, Outcome | No. of CPP* | AI methods | Predictors | Val. methods | Performance (AUC, Accuracy (Acc%), Sensitivity (SEN%), Specificity (SPE%), PPV/NPV (%), (95% CI)) | Risk of Bias**: Participants/Predictors/Outcome/Analysis/Overall | ||||
---|---|---|---|---|---|---|---|---|---|---|
Abdani et al. [30], Fast screening | 219 | DL, CNN | Imaging features | 5-FCV | Acc 94 | H | U | H | H | H |
Ahammed et al. [5], Early detection | 285 | ML, DL, CNN, SVM, RF, k-NN, LR, GNB, BNB, DT, XGB, MLP, NC, perceptron. | Imaging features | 10-FCV | AUC 95.52, Acc 94.03, SEN 94.03, SPE 97.01 | H | H | H | H | H |
Barstugan et al. [31], Early detection | 53 | ML, SVM | Imaging features | 10-FCV | Acc 99.68, SEN 93, SPE 100 | U | U | U | H | H |
Wu et al. [55], China, Fast and accurately identification | 368 | DL | Imaging features | TTS | AUC 0.905, Acc 83.3, SEN 82.3 | L | U | U | H | H |
Wang et al. [56], China, Triage | 1647 | DL | Imaging features | Ext. val. | AUC 0.953 (95% CI 0.949–0.959), SEN 92.3 (95% CI 91.4–93.2), SPE 85.1 (84.2–86.0), PPV 79 (77.7–80.3), NPV 94.8 (94.1–95.4) | L | U | U | H | H |
*CPP = COVID-19 Positive Patients, Abbreviations of medical terms included in this Table are provided in the Appendix.
**L: Low, H: High, U: Unclear